Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer. From the Manchester Lung Tumour Group.
Authors
Thatcher, NickSmith, David B
Lind, Michael J
Anderson, Heather
Barclay, J
Chopra, M P
Fitzgerald, M D
Affiliation
CRC Department of Medical Oncology, Christie Hospital and Holt Radium Institute, Manchester, England.Issue Date
1988-01-01